Real-time enrollment status for this hyperphosphatemia clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 7:59 PM UTC
| NCT Number | NCT06712654 |
| Recruiting Status | Recruiting |
| Condition | Hyperphosphatemia |
| Phase | PHASE2 |
| Target Enrollment | 168 participants |
| Active Locations | 24 sites in the US |
| Sponsor | R1 Therapeutics |
| Last Updated on CT.gov | August 26, 2026 (Yesterday) |
As of August 27, 2026: Clinical trial NCT06712654 is currently recruiting participants. This phase2 study for hyperphosphatemia is actively seeking new participants at 24 locations across the United States. The study is sponsored by R1 Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06712654 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06712654 was last updated Yesterday (August 26, 2026). HelloStudys verifies this status automatically.